SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction.

Sharp, A; Cornforth, C; Jackson, R; Harrold, J; Turner, MA; Kenny, L; Baker, PN; Johnstone, ED; Khalil, A; von Dadelszen, P; et al. Sharp, A; Cornforth, C; Jackson, R; Harrold, J; Turner, MA; Kenny, L; Baker, PN; Johnstone, ED; Khalil, A; von Dadelszen, P; Papageorghiou, AT; Alfirevic, Z (2019) Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction. Lancet Child Adolesc Health, 3 (3). e2-e3. ISSN 2352-4650 https://doi.org/10.1016/S2352-4642(19)30020-3
SGUL Authors: Khalil, Asma

[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (264kB) | Preview
Item Type: Article
Additional Information: © 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Lancet Child Adolesc Health
ISSN: 2352-4650
Language: eng
Dates:
DateEvent
March 2019Published
29 January 2019Published Online
14 January 2019Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
PubMed ID: 30704877
Web of Science ID: WOS:000458662400001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/111172
Publisher's version: https://doi.org/10.1016/S2352-4642(19)30020-3

Actions (login required)

Edit Item Edit Item